StockNews.com lowered shares of Rockwell Medical (NASDAQ:RMTI - Free Report) from a buy rating to a hold rating in a research report sent to investors on Thursday.
Several other analysts also recently weighed in on the company. Rodman & Renshaw initiated coverage on Rockwell Medical in a research note on Thursday, November 14th. They set a "buy" rating and a $5.00 price target on the stock. RODMAN&RENSHAW upgraded shares of Rockwell Medical to a "strong-buy" rating in a research note on Thursday, November 14th. Finally, HC Wainwright reiterated a "buy" rating and set a $9.00 price objective on shares of Rockwell Medical in a research note on Wednesday, September 11th.
Check Out Our Latest Stock Analysis on Rockwell Medical
Rockwell Medical Trading Down 6.4 %
NASDAQ RMTI opened at $2.33 on Thursday. Rockwell Medical has a 12-month low of $1.16 and a 12-month high of $5.15. The company has a fifty day simple moving average of $3.63 and a two-hundred day simple moving average of $2.64. The company has a quick ratio of 2.00, a current ratio of 2.41 and a debt-to-equity ratio of 0.33.
Institutional Trading of Rockwell Medical
Institutional investors and hedge funds have recently made changes to their positions in the business. Armistice Capital LLC boosted its holdings in Rockwell Medical by 22.5% in the 2nd quarter. Armistice Capital LLC now owns 3,221,640 shares of the company's stock valued at $5,670,000 after purchasing an additional 592,000 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of Rockwell Medical by 4.0% during the first quarter. Vanguard Group Inc. now owns 1,118,277 shares of the company's stock worth $1,856,000 after purchasing an additional 43,302 shares during the last quarter. Jane Street Group LLC acquired a new stake in Rockwell Medical during the 3rd quarter worth $534,000. Walleye Capital LLC acquired a new position in Rockwell Medical in the 3rd quarter valued at $435,000. Finally, Renaissance Technologies LLC lifted its holdings in shares of Rockwell Medical by 877.1% in the 2nd quarter. Renaissance Technologies LLC now owns 102,700 shares of the company's stock valued at $181,000 after buying an additional 92,189 shares during the period. 23.31% of the stock is currently owned by hedge funds and other institutional investors.
About Rockwell Medical
(
Get Free Report)
Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.
Read More
Before you consider Rockwell Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rockwell Medical wasn't on the list.
While Rockwell Medical currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
